二激素通过EPPK1-介导的MAPK/JUP信号传递促进膀癌细胞的增殖和入侵
Long Yang1, Wen Huang1, Xiaoyu Bai2
1Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Cell death & disease
|June 16, 2023
概括
二激素 (DHT) 通过涉及EPPK1和JUP的非雄激素受体 (AR) 途径促进膀癌 (BLCA) 的生长. 这一发现为BLCA治疗提供了潜在的新治疗点.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 膀癌 (BLCA) 的发病率在男性中更高,可能是由于雄激素水平的差异.
- 经典的雄激素受体 (AR) 途径与激素驱动的癌症有关,但由于AR表达低,其在BLCA中的作用尚不清楚.
研究的目的:
- 研究二二 (DHT) 在促进BLCA发育中的非AR介导途径.
- 为了确定BLCA治疗的新分子标.
主要方法:
- 在体外研究中,使用用DHT治疗的BLCA细胞.
- 在体内实验中,使用N--N-(4-氧) 氨酸 (BBN) 治疗的小鼠进行了实验.
- 免疫组织化学,DHT结合拉下测试,基因淘汰和西部涂抹.
主要成果:
- DHT显著增加了BLCA细胞的增殖和入侵,独立于AR途径.
- DHT与EPPK1直接相互作用,该基因在BLCA组织中表达高.
- DHT诱导的EPPK1激活了JUP表达和p38 MAPK信号通路,促进了瘤的生长.
结论:
- DHT通过涉及EPPK1,JUP和p38 MAPK的新型非AR途径促进BLCA的进展.
- 这种非AR途径对膀癌具有潜在的治疗点.
相关概念视频
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


